🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

CG Oncology, Inc.

CGON Healthcare
$71.96 $-1.44 (-1.96%)
Market Cap: $6.38 B
Gurus Holding
3
Popularity Rank
#2668
% of Shares Held
1.50%
Net Activity (Q2 2026)
+$26.25 M

Guru Ownership Trend

Guru Analysis for CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $95.66 M.

Top institutional holders include Jefferies Group and Ken Fisher.

Institutional sentiment is currently Bullish. This is evidenced by a $26.25 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 10.5%.

Key Holders

Top 5 by Value

$54.7 M
$32.47 M
$7.28 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$54.7 M
Total Buy Value
New Buys 1
Additions 0
-$28.45 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for CG Oncology, Inc. (CGON)

Major holders include Jefferies Group ($54.7 M), Ken Fisher ($32.47 M), Cliff Asness ($7.28 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.33 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $26.25 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited CGON. The total reported sell value was $28.45 M.

Yes, 1 managers opened new positions in CGON, and 0 increased their existing holdings. The total reported buy value was $54.7 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.36% New Buy 769,947 $54.7 M Q2 2026
0.01% Reduce -1.7% 456,978 $32.47 M Q2 2026
0.00% Reduce -10.5% 102,397 $7.28 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form